Therapeutic potential of neuromodulation for demyelinating diseases

Neuromodulation represents a cutting edge class of both invasive and non-invasive therapeutic methods which alter the activity of neurons. Currently, several different techniques have been developed - or are currently being investigated – to treat a wide variety of neurological and neuropsychiatric...

Full description

Bibliographic Details
Main Authors: Elliot H Choi, Chioma Nwakalor, Nolan J Brown, Joonho Lee, Michael Y Oh, In Hong Yang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=2;spage=214;epage=217;aulast=Choi
id doaj-f989fc9c9ac144a69f88b816ca1c8fe9
record_format Article
spelling doaj-f989fc9c9ac144a69f88b816ca1c8fe92020-11-25T02:30:49ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742021-01-0116221421710.4103/1673-5374.290876Therapeutic potential of neuromodulation for demyelinating diseasesElliot H ChoiChioma NwakalorNolan J BrownJoonho LeeMichael Y OhIn Hong YangNeuromodulation represents a cutting edge class of both invasive and non-invasive therapeutic methods which alter the activity of neurons. Currently, several different techniques have been developed - or are currently being investigated – to treat a wide variety of neurological and neuropsychiatric disorders. Recently, in vivo and in vitro studies have revealed that neuromodulation can also induce myelination, meaning that it could hold potential as a therapy for various demyelinating diseases including multiple sclerosis and progressive multifocal leukencepalopathy. These findings come on the heels of a paradigm shift in the view of myelin's role within the nervous system from a static structure to an active co-regulator of central nervous system plasticity and participant in neuron-mediated modulation. In the present review, we highlight several of the recent findings regarding the role of neural activity in altering myelination including several soluble and contact-dependent factors that seem to mediate neural activity-dependent myelination. We also highlight several considerations for neuromodulatory techniques, including the need for further research into spatiotemporal precision, dosage, and the safety and efficacy of transcranial focused ultrasound stimulation, an emerging neuromodulation technology. As the field of neuromodulation continues to evolve, it could potentially bring forth methods for the treatment of demyelinating diseases, and as such, further investigation into the mechanisms of neuron-dependent myelination as well as neuro-imaging modalities that can monitor myelination activity is warranted.http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=2;spage=214;epage=217;aulast=Choicentral nervous system; deep brain stimulation; myelination; neural activity; oligodendrocyte; optogenetic stimulation; transcranial electrical stimulation; transcranial focused ultrasound stimulation; transcranial magnetic stimulation
collection DOAJ
language English
format Article
sources DOAJ
author Elliot H Choi
Chioma Nwakalor
Nolan J Brown
Joonho Lee
Michael Y Oh
In Hong Yang
spellingShingle Elliot H Choi
Chioma Nwakalor
Nolan J Brown
Joonho Lee
Michael Y Oh
In Hong Yang
Therapeutic potential of neuromodulation for demyelinating diseases
Neural Regeneration Research
central nervous system; deep brain stimulation; myelination; neural activity; oligodendrocyte; optogenetic stimulation; transcranial electrical stimulation; transcranial focused ultrasound stimulation; transcranial magnetic stimulation
author_facet Elliot H Choi
Chioma Nwakalor
Nolan J Brown
Joonho Lee
Michael Y Oh
In Hong Yang
author_sort Elliot H Choi
title Therapeutic potential of neuromodulation for demyelinating diseases
title_short Therapeutic potential of neuromodulation for demyelinating diseases
title_full Therapeutic potential of neuromodulation for demyelinating diseases
title_fullStr Therapeutic potential of neuromodulation for demyelinating diseases
title_full_unstemmed Therapeutic potential of neuromodulation for demyelinating diseases
title_sort therapeutic potential of neuromodulation for demyelinating diseases
publisher Wolters Kluwer Medknow Publications
series Neural Regeneration Research
issn 1673-5374
publishDate 2021-01-01
description Neuromodulation represents a cutting edge class of both invasive and non-invasive therapeutic methods which alter the activity of neurons. Currently, several different techniques have been developed - or are currently being investigated – to treat a wide variety of neurological and neuropsychiatric disorders. Recently, in vivo and in vitro studies have revealed that neuromodulation can also induce myelination, meaning that it could hold potential as a therapy for various demyelinating diseases including multiple sclerosis and progressive multifocal leukencepalopathy. These findings come on the heels of a paradigm shift in the view of myelin's role within the nervous system from a static structure to an active co-regulator of central nervous system plasticity and participant in neuron-mediated modulation. In the present review, we highlight several of the recent findings regarding the role of neural activity in altering myelination including several soluble and contact-dependent factors that seem to mediate neural activity-dependent myelination. We also highlight several considerations for neuromodulatory techniques, including the need for further research into spatiotemporal precision, dosage, and the safety and efficacy of transcranial focused ultrasound stimulation, an emerging neuromodulation technology. As the field of neuromodulation continues to evolve, it could potentially bring forth methods for the treatment of demyelinating diseases, and as such, further investigation into the mechanisms of neuron-dependent myelination as well as neuro-imaging modalities that can monitor myelination activity is warranted.
topic central nervous system; deep brain stimulation; myelination; neural activity; oligodendrocyte; optogenetic stimulation; transcranial electrical stimulation; transcranial focused ultrasound stimulation; transcranial magnetic stimulation
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=2;spage=214;epage=217;aulast=Choi
work_keys_str_mv AT elliothchoi therapeuticpotentialofneuromodulationfordemyelinatingdiseases
AT chiomanwakalor therapeuticpotentialofneuromodulationfordemyelinatingdiseases
AT nolanjbrown therapeuticpotentialofneuromodulationfordemyelinatingdiseases
AT joonholee therapeuticpotentialofneuromodulationfordemyelinatingdiseases
AT michaelyoh therapeuticpotentialofneuromodulationfordemyelinatingdiseases
AT inhongyang therapeuticpotentialofneuromodulationfordemyelinatingdiseases
_version_ 1724827625061351424